1. Wei, Sisi, Huang, Xuan, Zhu, Qing, Lei, Enjun, Li, Yong. 2024. TRIM65 deficiency alleviates renal fibrosis through NUDT21-mediated alternative polyadenylation. In Cell death and differentiation, 31, 1422-1438. doi:10.1038/s41418-024-01336-z. https://pubmed.ncbi.nlm.nih.gov/38951701/
2. Zhang, Qi, Li, Yong, Zhu, Qing, Xin, Hongbo, Huang, Xuan. 2024. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3. In Cell death & disease, 15, 355. doi:10.1038/s41419-024-06741-3. https://pubmed.ncbi.nlm.nih.gov/38777825/
3. Shen, Sheng, Yan, Ran, Xie, Zhanglian, Sun, Jian, Guo, Haitao. 2024. Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription. In Viruses, 16, . doi:10.3390/v16060890. https://pubmed.ncbi.nlm.nih.gov/38932182/
4. Liu, HuiTing, Zhou, ZhiXiang, Deng, HuaNian, Ren, Zhong, Jiang, ZhiSheng. 2023. Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway. In European journal of pharmacology, 949, 175735. doi:10.1016/j.ejphar.2023.175735. https://pubmed.ncbi.nlm.nih.gov/37080331/
5. Wu, Ying-Ting, Ma, Si-Yu, Sun, Wen-Qin, Zhang, Qin, Chen, Hui-Fen. . TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6. In The Journal of clinical endocrinology and metabolism, 106, 526-538. doi:10.1210/clinem/dgaa804. https://pubmed.ncbi.nlm.nih.gov/33146694/
6. Li, Yang, Ma, Chengyuan, Zhou, Tong, Sun, Luyao, Yu, Zhenxiang. 2016. TRIM65 negatively regulates p53 through ubiquitination. In Biochemical and biophysical research communications, 473, 278-282. doi:10.1016/j.bbrc.2016.03.093. https://pubmed.ncbi.nlm.nih.gov/27012201/
7. Li, Shitao, Wang, Lingyan, Fu, Bishi, Dorf, Martin E. . Trim65: a cofactor for regulation of the microRNA pathway. In RNA biology, 11, 1113-21. doi:10.4161/rna.36179. https://pubmed.ncbi.nlm.nih.gov/25483047/
8. Chen, Geng, Zhou, Tong, Liu, Ying, Yu, Zhenxiang. 2018. Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells. In Biochemical and biophysical research communications, 506, 698-702. doi:10.1016/j.bbrc.2018.10.130. https://pubmed.ncbi.nlm.nih.gov/30454706/
9. Li, Yong, Huang, Xuan, Guo, Fang, Xin, Hong-Bo, Fu, Mingui. . TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation. In Journal of molecular cell biology, 12, 190-201. doi:10.1093/jmcb/mjz077. https://pubmed.ncbi.nlm.nih.gov/31310649/
10. Lu, Yongbin, Xiao, Yi, Yang, Jingru, Ling, Xiaoling, Zhang, Tao. 2022. TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein. In Oxidative medicine and cellular longevity, 2022, 4374978. doi:10.1155/2022/4374978. https://pubmed.ncbi.nlm.nih.gov/36035221/
智鼠故事 
